On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...